Quelle est la Part des Régimes Publics d’Assurance- Médicament aux Résultats de Sante? Une Étude de Cas Multiples au Nouveau-Brunswick, en Ontario, et au Québec
DOI:
https://doi.org/10.18192/riss-ijhs.v2i2.1517Keywords:
Drug insurance plan, province, health outcomes, agingAbstract
Canadian provincial and territorial drug plans vary considerably in terms of eligibility criteria, and most of the insurance plans provided are subject to caps, cost sharing and exclusions. In fact, Canadians have unequal access to prescription medications, depending on their socio-economic status and place of residence. This comes at time then the effects of population aging, an increasing number of people with multiple chronic illnesses and innovations in the prescription medications field have brought about an increase in spending on these products. The question raised by this study is does a province with a better prescription drug plan have a healthier population?
This study compared coverage of prescription drug plans among people 65 years old and over in three provinces: New Brunswick, Ontario and Quebec. The results of our study suggest that senior citizen health does not seem to improve. Therefore, it is impera- tive that additional research be conducted to determine the true impact of prescription drug plans on health outcomes. This would allow for the creation of tailor-made, better-targeted programs and policies to meet community needs more adequately.
References
Conseil canadien sur la santé. (2007). Schémas de population – Maladies chroniques au Canada : Supplément de données, Importance du renouvellement des soins de santé : À l’écoute des Canadiens atteints de maladies chroniques. Ottawa, ON: Conseil canadien sur la santé.
Coombes, M. E., Morgan, S. G., Barer, M. L., & Pagliccia, N. (2004). Who’s the fairest of them all? Which provincial pharmacare model would best protect Canadians against catastrophic drug costs? Longwoods Review, 2(3), 13-26. doi: 10.12927/hcq.2004.17236
Demers, V., Melo, M., Jackevicius, C., Cox, J., Kalavrouziotis, D., Rinfret, S., ... & Pilote, L. (2008). Comparison of provincial prescription drug plans and the impact on patients’ annual drug expenditures. Canadian Medical Association Journal, 178(4), 405-409. doi: 10.1503/ cmaj.070587
Fraser, K., & Shillington, R. (2005). Protecting the unprotected. Canadian Healthcare Manager, pp. 16-17.
Imbeau, L. M., Chenard, K., & Dudas, A. (2002). Les conditions de la viabilité d’un système public de santé au Canada. Commission sur l’avenir des soins de santé au Canada Publication. Publié en ligne au http://sbisrvntweb.uqac.ca/archivage/14806707.pdf
Institut canadien d’information sur la santé (ICIS). (2010a). Dépenses en médicaments au Canada, de 1985 à 2009. Ottawa, ON: Institut canadien d’information sur la santé.
Institut canadien d’information sur la santé (ICIS). (2010b). Utilisation des médicaments chez les personnes âgées dans le cadre des régimes publics d’assurance médicaments au Canada, 2002 à 2008. Ottawa, ON: Institut canadien d’information sur la santé.
Kapur, V., & Basu, K. (2005). Drug coverage in Canada: Who is at risk? Health Policy, 71(2), 181-193.
Morgan, S. (2004). Drug spending in Canada: Recent trends and causes. Medical Care, 42(7), 635-642. Retrieved from http://www.jstor.org/stable/4640798
Paris, V., & Docteur, E. (2006). Pharmaceutical pricing and reimbursement policies in Canada. OECD Health Working Papers, No. 24. OECD Publishing. Retrieved from http:// dx.doi.org/10.1787/346071162287
Robyn, T. (2001). Adverse events associated with prescription drug cost-sharing among poor and elderly persons. Journal of American Medical Association, 285(4), 421-429. doi: 10.1001/jama.285.4.421
Romanow, R. J. (2002). Guidé par nos valeurs: L’avenir des soins de santé au Canada. Commission sur l’avenir des soins de santé au Canada Publication. Publié en ligne au http://publications.gc.ca/site/fra/9.630832/ publication.html
Statistique Canada. Tableau 102-0121 : Espérance de vie en fonction de la santé, à la naissance et à 65 ans, selon le sexe et le groupe de revenu, Canada et provinces, occasionnel (années), CANSIM (base de données).
Tambay, J-L., Catlin, G. Plan d’échantillonnage de l’Enquête nationale sur la santé de la population. Rapports sur la santé 1995, 7(1), 29-38. Publié en ligne au http:// www5.statcan.gc.ca/olc-cel/olc.action?ObjId=82-003- X19950011661&ObjType=47&lang=fr
Tamblyn, R. M. (2005). Prescription drug coverage: An essential service or a fringe benefit? Canadian Medical Association Journal, 173(11), 1343-1344. doi: 10.1503/ cmaj.051153
Willcox, S. M., Himmelstein, D. U., & Woolhandler, S. (1994). Inappropriate drug prescribing for the community-dwelling elderly. Journal of the American Medical Association, 272(4), 292-296. doi: 10.1001/ jama.1994.03520040054040
Yin, R. K. (1994). Case study research: Design and methods. Thousand Oaks, CA: Sage.
Downloads
Published
Issue
Section
License
- All authors published in the IJHS will retain copyright of their article.
- Authors grant the IJHS the right of first publication of their submitted articles.
- All articles published in the IJHS are licensed under a Creative Commons Attribution License that allows others to share articles if original authors and journal of initial publication are acknowledged.
- The IJHS is published online and in print, therefore the journal is not responsible for any unauthorized misuse of published content in either electronic or print form
- The IJHS retains the serial distribution rights to all contents
- It is the responsibility of the authors and not the IJHS to ensure proper permissions for all cited work have been obtained
